Application of cine nuclear magnetic resonance imaging for sequential evaluation of response to angiotensin-converting enzyme inhibitor therapy in dilated cardiomyopathy

Neil E. Doherty, Klaus C. Seelos, Jun Ichi Suzuki, Gary R Caputo, Margaret O'Sullivan, Samuel M. Sobol, Patricia Cavero, Kanu Chatterjee, William W. Parmley, Charles B. Higgins

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Cine nuclear magnetic resonance (NMR) imaging was used to serially measure cardiovascular function in 17 patients with New York Heart Association class II or III heart failure and left ventricular ejection fraction ≤45% who were treated for 3 months with benazepril hydrochloride, a new angiotensin-converting enzyme inhibitor, while continuing treatment with diuretic agents and digoxin. Interobserver reproducibilities for ejection fraction (r = 0.94, SEE 3.3%), end-systolic volume (r = 0.98, SEE 10.6 ml), end-diastolic volume (r = 0.99, SEE 8.29 ml), end-systolic mass (r = 0.96, SEE 15.4 g), end-systolic wall stress (r = 0.91, SEE 10 dynes · s · cm-5) and end-systolic stress/volume ratio (r = 0.85, SEE 0.13) demonstrated applicability of cine NMR imaging for the serial assessment of cardiovascular function in response to pharmacologic interventions in patients with heart failure. During 12 weeks of treatment with benazepril, ejection fraction increased progressively from 22.7 ± 2.2% (mean ± SEM) to 36 ± 2.2% (p < 0.05), end-diastolic volume decreased from 166 ±14 to 158 ± 12 ml (p = NS), end-systolic volume decreased from 118 ± 12 to 106 ± 11 ml (p < 0.05), left ventricular mass decreased from 235 ± 13 to 220 ± 12 g (p < 0.05), end-systolic wall stress decreased 29% from 90 ± 5 to 64 ± 5 dynes · s · cm-5 (p < 0.05), end-systolic pressure decreased from 92.6 ± 3.7 to 78.8 ± 5.3 (p < 0.05) and end-systolic stress/volume ratio, a load-independent index of contractility, decreased from 0.83 ± 0.05 to 0.67 ± 0.06 (p < 0.05), demonstrating that improved ejection fraction is due to afterload reduction.

Original languageEnglish (US)
Pages (from-to)1294-1302
Number of pages9
JournalJournal of the American College of Cardiology
Volume19
Issue number6
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Cine Magnetic Resonance Imaging
Enzyme Therapy
Dilated Cardiomyopathy
Angiotensin-Converting Enzyme Inhibitors
Magnetic Resonance Spectroscopy
Heart Failure
Digoxin
Diuretics
Stroke Volume
Blood Pressure
Therapeutics
benazepril

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Application of cine nuclear magnetic resonance imaging for sequential evaluation of response to angiotensin-converting enzyme inhibitor therapy in dilated cardiomyopathy. / Doherty, Neil E.; Seelos, Klaus C.; Suzuki, Jun Ichi; Caputo, Gary R; O'Sullivan, Margaret; Sobol, Samuel M.; Cavero, Patricia; Chatterjee, Kanu; Parmley, William W.; Higgins, Charles B.

In: Journal of the American College of Cardiology, Vol. 19, No. 6, 1992, p. 1294-1302.

Research output: Contribution to journalArticle

Doherty, Neil E. ; Seelos, Klaus C. ; Suzuki, Jun Ichi ; Caputo, Gary R ; O'Sullivan, Margaret ; Sobol, Samuel M. ; Cavero, Patricia ; Chatterjee, Kanu ; Parmley, William W. ; Higgins, Charles B. / Application of cine nuclear magnetic resonance imaging for sequential evaluation of response to angiotensin-converting enzyme inhibitor therapy in dilated cardiomyopathy. In: Journal of the American College of Cardiology. 1992 ; Vol. 19, No. 6. pp. 1294-1302.
@article{013541d233f64043bb7e7296f60faf31,
title = "Application of cine nuclear magnetic resonance imaging for sequential evaluation of response to angiotensin-converting enzyme inhibitor therapy in dilated cardiomyopathy",
abstract = "Cine nuclear magnetic resonance (NMR) imaging was used to serially measure cardiovascular function in 17 patients with New York Heart Association class II or III heart failure and left ventricular ejection fraction ≤45{\%} who were treated for 3 months with benazepril hydrochloride, a new angiotensin-converting enzyme inhibitor, while continuing treatment with diuretic agents and digoxin. Interobserver reproducibilities for ejection fraction (r = 0.94, SEE 3.3{\%}), end-systolic volume (r = 0.98, SEE 10.6 ml), end-diastolic volume (r = 0.99, SEE 8.29 ml), end-systolic mass (r = 0.96, SEE 15.4 g), end-systolic wall stress (r = 0.91, SEE 10 dynes · s · cm-5) and end-systolic stress/volume ratio (r = 0.85, SEE 0.13) demonstrated applicability of cine NMR imaging for the serial assessment of cardiovascular function in response to pharmacologic interventions in patients with heart failure. During 12 weeks of treatment with benazepril, ejection fraction increased progressively from 22.7 ± 2.2{\%} (mean ± SEM) to 36 ± 2.2{\%} (p < 0.05), end-diastolic volume decreased from 166 ±14 to 158 ± 12 ml (p = NS), end-systolic volume decreased from 118 ± 12 to 106 ± 11 ml (p < 0.05), left ventricular mass decreased from 235 ± 13 to 220 ± 12 g (p < 0.05), end-systolic wall stress decreased 29{\%} from 90 ± 5 to 64 ± 5 dynes · s · cm-5 (p < 0.05), end-systolic pressure decreased from 92.6 ± 3.7 to 78.8 ± 5.3 (p < 0.05) and end-systolic stress/volume ratio, a load-independent index of contractility, decreased from 0.83 ± 0.05 to 0.67 ± 0.06 (p < 0.05), demonstrating that improved ejection fraction is due to afterload reduction.",
author = "Doherty, {Neil E.} and Seelos, {Klaus C.} and Suzuki, {Jun Ichi} and Caputo, {Gary R} and Margaret O'Sullivan and Sobol, {Samuel M.} and Patricia Cavero and Kanu Chatterjee and Parmley, {William W.} and Higgins, {Charles B.}",
year = "1992",
doi = "10.1016/0735-1097(92)90337-M",
language = "English (US)",
volume = "19",
pages = "1294--1302",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Application of cine nuclear magnetic resonance imaging for sequential evaluation of response to angiotensin-converting enzyme inhibitor therapy in dilated cardiomyopathy

AU - Doherty, Neil E.

AU - Seelos, Klaus C.

AU - Suzuki, Jun Ichi

AU - Caputo, Gary R

AU - O'Sullivan, Margaret

AU - Sobol, Samuel M.

AU - Cavero, Patricia

AU - Chatterjee, Kanu

AU - Parmley, William W.

AU - Higgins, Charles B.

PY - 1992

Y1 - 1992

N2 - Cine nuclear magnetic resonance (NMR) imaging was used to serially measure cardiovascular function in 17 patients with New York Heart Association class II or III heart failure and left ventricular ejection fraction ≤45% who were treated for 3 months with benazepril hydrochloride, a new angiotensin-converting enzyme inhibitor, while continuing treatment with diuretic agents and digoxin. Interobserver reproducibilities for ejection fraction (r = 0.94, SEE 3.3%), end-systolic volume (r = 0.98, SEE 10.6 ml), end-diastolic volume (r = 0.99, SEE 8.29 ml), end-systolic mass (r = 0.96, SEE 15.4 g), end-systolic wall stress (r = 0.91, SEE 10 dynes · s · cm-5) and end-systolic stress/volume ratio (r = 0.85, SEE 0.13) demonstrated applicability of cine NMR imaging for the serial assessment of cardiovascular function in response to pharmacologic interventions in patients with heart failure. During 12 weeks of treatment with benazepril, ejection fraction increased progressively from 22.7 ± 2.2% (mean ± SEM) to 36 ± 2.2% (p < 0.05), end-diastolic volume decreased from 166 ±14 to 158 ± 12 ml (p = NS), end-systolic volume decreased from 118 ± 12 to 106 ± 11 ml (p < 0.05), left ventricular mass decreased from 235 ± 13 to 220 ± 12 g (p < 0.05), end-systolic wall stress decreased 29% from 90 ± 5 to 64 ± 5 dynes · s · cm-5 (p < 0.05), end-systolic pressure decreased from 92.6 ± 3.7 to 78.8 ± 5.3 (p < 0.05) and end-systolic stress/volume ratio, a load-independent index of contractility, decreased from 0.83 ± 0.05 to 0.67 ± 0.06 (p < 0.05), demonstrating that improved ejection fraction is due to afterload reduction.

AB - Cine nuclear magnetic resonance (NMR) imaging was used to serially measure cardiovascular function in 17 patients with New York Heart Association class II or III heart failure and left ventricular ejection fraction ≤45% who were treated for 3 months with benazepril hydrochloride, a new angiotensin-converting enzyme inhibitor, while continuing treatment with diuretic agents and digoxin. Interobserver reproducibilities for ejection fraction (r = 0.94, SEE 3.3%), end-systolic volume (r = 0.98, SEE 10.6 ml), end-diastolic volume (r = 0.99, SEE 8.29 ml), end-systolic mass (r = 0.96, SEE 15.4 g), end-systolic wall stress (r = 0.91, SEE 10 dynes · s · cm-5) and end-systolic stress/volume ratio (r = 0.85, SEE 0.13) demonstrated applicability of cine NMR imaging for the serial assessment of cardiovascular function in response to pharmacologic interventions in patients with heart failure. During 12 weeks of treatment with benazepril, ejection fraction increased progressively from 22.7 ± 2.2% (mean ± SEM) to 36 ± 2.2% (p < 0.05), end-diastolic volume decreased from 166 ±14 to 158 ± 12 ml (p = NS), end-systolic volume decreased from 118 ± 12 to 106 ± 11 ml (p < 0.05), left ventricular mass decreased from 235 ± 13 to 220 ± 12 g (p < 0.05), end-systolic wall stress decreased 29% from 90 ± 5 to 64 ± 5 dynes · s · cm-5 (p < 0.05), end-systolic pressure decreased from 92.6 ± 3.7 to 78.8 ± 5.3 (p < 0.05) and end-systolic stress/volume ratio, a load-independent index of contractility, decreased from 0.83 ± 0.05 to 0.67 ± 0.06 (p < 0.05), demonstrating that improved ejection fraction is due to afterload reduction.

UR - http://www.scopus.com/inward/record.url?scp=0026603207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026603207&partnerID=8YFLogxK

U2 - 10.1016/0735-1097(92)90337-M

DO - 10.1016/0735-1097(92)90337-M

M3 - Article

C2 - 1564230

AN - SCOPUS:0026603207

VL - 19

SP - 1294

EP - 1302

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 6

ER -